LEVI has reported Q2 2026 results, and the week's most interesting question is how the dust settles — shorts have already covered aggressively into the print, analysts raised targets in unison beforehand, yet the stock ended the week down 0.7% to $24.66.
The short-covering story that dominated pre-earnings notes has now largely played out. Short interest has fallen to 6.8% of free float — down 30% over the past month, a sustained unwind that has stripped roughly 3 million shares from the short book since late May. The borrow market reflects that retreat clearly. Cost to borrow has collapsed 74% on the week to just 0.49%, reversing the brief spike to 1.90% that appeared in late June. Availability has loosened to 835% — roughly eight shares available for every one borrowed — well up from the tighter levels of mid-June. The ORTEX short score sits at 46, near the middle of the universe and down from readings above 48 two weeks ago. Bears who wanted out before the print have largely left. Options positioning has also normalised post-earnings: the put/call ratio eased to 1.26, only fractionally above its 20-day mean of 1.24 and well off the 1.31–1.32 readings that had been elevated for weeks into the catalyst. The defensive skew that characterised the setup going in has unwound.
The Street lined up constructively into the number, and the data supports their optimism more than it challenges it. JP Morgan raised its target to $32 on July 2, maintaining Overweight. Telsey Advisory Group lifted to $30 and Raymond James to $27, both reiterating positive ratings. Even Citi, the cautious voice in the group, lifted its neutral target from $23 to $25. The consensus mean now sits at $27.73 — about 12% above the current price — and the direction of analyst travel has been uniformly upward. The bull case centres on DTC expansion, women's and tops category growth, and international revenue momentum. Bears point to tariff uncertainty and macro softness in consumer discretionary, where overall spending on apparel remains fragile. The 12-month forward EPS momentum factor ranks in the 8th percentile, a reminder that while the recent prints have been solid, the forward setup carries some compression risk.
The founding family's behaviour this week adds a counterpoint worth keeping in mind. The Haas family — who collectively hold well over 50% of the company across multiple members — sold approximately $16.3 million in shares in a tight cluster around June 10–12, at prices near $24. Robert D. Haas alone sold nearly 694,000 shares across two sessions. The 90-day net insider flow now runs to almost $39.6 million in sales. These transactions appear to be systematic — prices achieved were broadly in line with where the stock trades now — but the family's consistent trimming around the $24 handle, both before and after a catalyst, is the kind of structural supply that tends to cap near-term upside at a level the stock has now reached twice.
Among peers, PVH gained 5.1% on the week and UAA jumped 8.9%, while RL slipped 0.6% — broadly in line with LEVI's flat-to-down finish. The relative underperformance against the more volatile names in the group is notable given LEVI's pre-earnings analyst tailwind, and may reflect the Haas family supply overhang absorbing demand that would otherwise have moved the price.
The key watch now is whether the earnings report itself — with guidance on tariff mitigation and DTC progress — shifts the analyst consensus materially beyond the $27.73 mean, or whether the stock continues to run into Haas-family selling at the low-to-mid $20s.
See the live data behind this article on ORTEX.
Open LEVI on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
